arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

MEDIFAST INC

MED
$12.61 ▲ +0.50 (+4.13%) at close
Consumer Staples ·Miscellaneous Food Preparations & Kindred Products ·USMiscellaneous Food Preparations & Kindred Products
67 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

MEDIFAST INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $138.8M
Dividend Yield
Revenue Growth -34.3%
Op. Margin -4.3%
ROIC -1.8%
FCF / Share $-0.08
Trailing P/E
Price / Book 0.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$76.04M
↓ -34.3%
Net Income Profit after all expenses
$-2.12M
↓ -174.9%
Operating Margin Operating profit as % of sales
-4.3%
↑ +58.3% 21th
FCF / Share Free cash flow per share
$-0.08
↓ -107.8%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
23
Returns
35
Cash Quality
20

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters